Status:
RECRUITING
Evaluation of the Efficacy and Safety of Microneedling Combined With Botulinum Toxin-A Versus Meso-Botox Injection in the Treatment of Atrophic Acne Scars: A Split-face Comparative Study
Lead Sponsor:
Sohag University
Conditions:
Atrophic Acne Scar
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Post-acne scars are psychologically disappointing and therapeutically challenging condition. No standard treatment for atrophic acne scars. Micro-Botox, is a highly diluted BTX-A which could be injec...
Eligibility Criteria
Inclusion
- Patients with atrophic post-acne scars.
Exclusion
- Pregnancy and lactation. Ongoing infection within the targeted treatment region or active acne lesions. Skin cancer, or precancerous lesions. History of keloid formation. History of allergy to BTX. Patients with neuromuscular diseases, patients with pre-existing medical conditions that cause muscle weakness as myasthenia gravis.
- Patients who underwent Botox injection, during the last 6 months. Patients who were under treatment by systemic retinoids in the previous 6 months.
- Patients with a history of chemical peels or laser procedures within 6 months of the study period.
- Patients with bleeding disorders.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06544993
Start Date
May 1 2024
End Date
May 1 2025
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt, Sohag